I am proud to have survived having diabetes for 52 years and 4 months. For most of those years about the only change in care that I noticed was that needles got smaller and sharper. The past two years have been really exciting with trends in diabetes care that should produce significant improvements in the outcomes of diabetes interventions. The thing that excites me the most is the potential to slow or stop the progression of the microvascular complications of diabetes with the development of the Protein Kinase C inhibitor that Eli Lilly and Co. has in clinical trials. LY333531 has the potential to be one of the biggest breakthroughs in diabetes care. I am also impressed with the development of insulin’s that can be used to provide really good management of diabetes both fasting and after meals. I am a strong believer that post-prandial hyperglycemia needs to be confronted and treated to reduce diabetes complications. 3rd, we are making progress on improved methods to monitor diabetes. Self-Monitoring of Blood Glucose, next to insulin, is the biggest thing that has happened in diabetes care in my life. I like the newer products that are easy to program and get small amounts of blood to get a blood glucose reading. 4th, the studies that have proven that near normalization of blood glucose reduces complications is great. This combined with the ADA’s Standards of Diabetes Care has begun to create a treatment for diabetes patients that provides improved outcomes of care when the Standards are followed. Lastly, I have spent much of my life trying to get well educated pharmacists more involved in providing diabetes disease state management and that process is beginning to occur much more often and it has been proven in many studies that pharmacists can make a significant difference in the care of their diabetes patients. There has never been a more exciting time for diabetes patients to be empowered to take charge of their diabetes and feel better and avoid complications. I hope I have another 10 or more years to experience some of the great discoveries that are on the horizon.” Sincerely, R. Keith Campbell, R.Ph., MBA, FASHP, CDE Professor: of Pharmacy Washington State University School of Pharmacy Dr. Campbell is an expert in diabetes and its treatments as well as how to educate and empower patients to improve their outcomes of care and how to market diabetes care products.